Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Recombinant Human CAMP/LL37/FALL39/Cathelicidin His Protein
SDP

Catalog No. NBP222738
Click to view available options
Quantity:
0.02 mg

Highly purified. Generating reliable and reproducible results. Applications: SDS-Page

A denatured recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 34-173 of Human CAMP/LL37/FALL39/Cathelicidin The Recombinant Human CAMP/LL37/FALL39/Cathelicidin Protein is derived from E. coli. The Recombinant Human CAMP/LL37/FALL39/Cathelicidin Protein has been validated for the following applications: SDS-Page.

Specifications

Accession Number NP_004336.3
For Use With (Application) SDS-PAGE
Formulation 20mM Tris-HCl buffer (pH 8.0), 0.4M UREA, 10% glycerol
Gene ID (Entrez) 820
Molecular Weight (g/mol) 18.4kDa
Name CAMP/LL37/FALL39/Cathelicidin Protein
Purification Method SDS-PAGE
Quantity 0.02 mg
Source E. Coli
Immunogen CAMP, 34-173aa, Human, His tag, E.coli MGSSHHHHHH SSGLVPRGSH MGSQVLSYKE AVLRAIDGIN QRSSDANLYR LLDLDPRPTM DGDPDTPKPV SFTVKETVCP RTTQQSPEDC DFKKDGLVKR CMGTVTLNQA RGSFDISCDK DNKRFALLGD FFRKSKEKIG KEFKRIVQRI KDFLRNLVPR TES
Storage Requirements −20°C or −80°C. Avoid freeze-thaw cycles.
Regulatory Status RUO
Conjugate Unconjugated
Species Human
Recombinant Recombinant
Research Category Immunology
Purity or Quality Grade >85%, by SDS-PAGE
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.